115 studies found for:    "Gout"
Show Display Options
Rank Status Study
21 Completed Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Condition: Gout
Interventions: Drug: lesinurad;   Drug: Placebo
22 Completed A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
Conditions: Gout;   Hyperuricemia;   Arthritis;   Joint Disease;   Renal Insufficiency
Interventions: Drug: Placebo;   Drug: Ulodesine (BCX4208) 5 mg;   Drug: Ulodesine (BCX4208) 10 mg
23 Completed
Has Results
Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol;   Drug: Placebo
24 Active, not recruiting Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEM
Conditions: Osteoarthritis;   Post-traumatic Arthritis;   Gout;   Pseudo-gout
Intervention: Device: SIGMA HP PARTIAL KNEE
25 Completed PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
Condition: Intercritical Gout
Intervention: Drug: rilonacept
26 Completed
Has Results
Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients
Condition: Acute Gout
Interventions: Drug: Canakinumab;   Drug: Triamcinolone acetonide
27 Completed Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Conditions: Moderate to Severe Gout;   Hyperuricemia
Interventions: Drug: Combination 400;   Drug: Allopurinol;   Drug: Combination 600
28 Completed
Has Results
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.
Condition: Acute Gout
Interventions: Drug: Canakinumab 150 mg;   Drug: Triamcinolone acetonide 40 mg;   Drug: Placebo to canakinumab;   Drug: Placebo to triamcinolone acetonide
29 Active, not recruiting A Proof-of-Concept Study Of AC-201 to Prevent Gout Flares
Condition: Gout Flares
Interventions: Drug: AC-201 50mg Capsule BID for 16 Weeks;   Drug: Placebo Capsule BID for 16 Weeks
30 Completed
Has Results
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study
Condition: Acute Gout
Interventions: Drug: Canakinumab 150 mg;   Drug: Triamcinolone acetonide 40 mg;   Drug: Placebo to canakinumab;   Drug: Placebo to triamcinolone acetonide
31 Completed
Has Results
Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
Condition: Chronic Gout Refractory to Conventional Therapy
Intervention: Drug: pegloticase 8 mg i.v.
32 Completed Study Utilizing Rilonacept in Gout Exacerbations
Condition: Acute Gout Flare
Interventions: Drug: rilonacept;   Drug: indomethacin;   Other: placebo
33 Completed
Has Results
Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol
34 Completed RDEA3170 Monotherapy in Subjects With Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: RDEA3170 5 mg;   Drug: RDEA3170 10 mg;   Drug: RDEA3170 12.5 mg
35 Completed Open-Label Lesinurad Monotherapy Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
36 Completed A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
Condition: Gout
Interventions: Drug: febuxostat;   Drug: Allopurinol
37 Completed Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
Conditions: Hyperuricemia;   Gout
Interventions: Drug: Arhalofenate;   Drug: Placebo comparator
38 Completed
Has Results
Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout
Condition: Gout
Interventions: Other: placebo;   Biological: pegloticase
39 Not yet recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
40 Not yet recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
Condition: Gout
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years